Surgical management of metastatic spinal tumors: a narrative review emphasizing patient selection, operative timing, minimally invasive approaches, and precision oncology
Purpose: Metastatic spinal tumors (MSTs) develop in 30%–40% of all patients with cancer and are a leading cause of cancer-related neurological impairment. Metastatic epidural spinal cord compression (MESCC) occurs in 5%–14% of patients during their lifetime and constitutes an oncological emergency because it can cause...